Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Ezose Sciences Receives Grant from Michael J. Fox Foundation

Published: Thursday, February 20, 2014
Last Updated: Thursday, February 20, 2014
Bookmark and Share
Foundation to apply Ezose’s Glycan Map technology to investigating the role of glycans in Parkinson’s disease.

Ezose’s Glycan Map technology enables automated analysis of glycans, which attach to proteins in the body and affect their biochemical function. The speed, scope, and quantitative power of this technology ho ld the potential for discovering novel glycan changes associated with altered protein function during the onset and progression of wide - ranging diseases, including Parkinson’s disease and other neurological disorders. Glycan s could serve as novel biomarkers for guiding clinical management and drug development and provide insight into disease mechanism and novel drug targets. 

The research funded by the foundation will be performed in Ezose’s laboratories, where the Glycan Map assay will be used to compare glycan profiles in brain - stem tissue from rat models of Parkinson’s disease and control rats over time and with respect to development of symptoms. 

“The Michael J. Fox Foundation has brought a tireless sense of urgency to advancing research in to Parkinson’s disease,” said Ryuichi Kiyama, Ph.D., Chairman and Chief Executive Officer of Ezose. “We look forward to bringing that spirit as well as our technical capabilities to this novel research project.” 

Mark Frasier, Ph.D., Vice President of Research Programs at The Michael J. Fox Foundation, commented: “Two important steps toward the development of a disease - modifying therapy for Parkinson’s are greater understanding of the underlying pathology of the disease and validation of a reliable biomarker. Ezose’s glycan analysis offers a new approach to serve those goals and bring us closer to a Parkinson’s cure.” 


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Ezose Sciences Enters Glycomics Research Agreement with Kyowa Hakko Kirin
Kyowa Hakko Kirin to Fund Projects Exploiting Ezose’s GlycanMap® technology.
Tuesday, January 29, 2013
Ezose Sciences and Hirosaki University to Collaborate in Glycomics Research
International study will focus on urologic cancers through use of Ezose’s GlycanMap® platform.
Wednesday, May 02, 2012
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Virus Inspired Cell Cargo Ships
Virus-inspired container design may lead to cell cargo ships following construction of ten large, two-component, icosahedral protein complexes.
Protein Reinforces Growth of Damaged Muscles
Biologists have found a protein involved in stem cells that bolsters damaged muscle tissue growth - potential for muscle degeneration treatments.
Structure of Cold Virus Solved
Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.
New Protein Model Could Accelerate Drug Development
Stony Brook-led international research team creates ultra-fast approach to model protein interactions.
Researchers Can Control Genes Involved in Cancer
A new way to control the activity of a protein, that is often upregulated in cancer, has been discovered by Moffitt researchers through monoubiquitination mechanism.
Mitochondrial Role in Metastatic Cancer
Researchers have manipulated proteins, sourced from tumour cells, that are essential for maintaining tumour cells and in doing so, have significantly reduced the ability of cancer cells.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!